Twice Yearly Treatment for the Control of LF
Not Applicable
- Conditions
- Lymphatic Filariasis
- Registration Number
- PACTR201702002012425
- Lead Sponsor
- EDCTP
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 1440
Inclusion Criteria
1. Residency in the disease endemic community for at least 12 months
2. Willingness to provide informed consent/assent
3. Willingness to donate blood (per the protocol)
Exclusion Criteria
1. Recent residents (<12 months)
2. Inability to give informed consent
3. Pregnant and lactating women
4. Children below the age of 5.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change from baseline prevalence of Lymphatic Filariasis at 24 months
- Secondary Outcome Measures
Name Time Method ongitudinal assessment of transmission dynamics of Lymphatic Filariasis for modelling the impact of treatment ;Evaluation of community acceptability of twice-yearly treatment, through questionnaires and focus group discussions ;Feasibility of scale-up of twice-yearly treatment, through questionnaires and focus group discussions